Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Southeast Asian J Trop Med Public Health ; 2007 Nov; 38(6): 979-82
Artigo em Inglês | IMSEAR | ID: sea-34039

RESUMO

Antiplasmodial 9-anilinoacridine derivatives exert their effects either by inhibiting DNA topoisomerase (topo) II or by interfering with heme crystallization within the parasite acidic food vacuole. Previous studies have shown that analogs of 9-anilinoacridine containing 3,6-diamino substitutions (in the acridine ring) inhibit Plasmodium falciparum DNA topo II in situ, whereas those with a 3,6-diCl substitution act by inhibiting beta-hematin formation, a property also seen with 3,6-diamino-1'-dimethyl-9-anilinoacridine (DDAA). To understand this seemingly anomalous property of DDAA, studies of its interaction with hematin and localization within the parasite food vacuole were undertaken. A weak interaction with hematin was demonstrated spectroscopically. Antagonism of DDAA inhibition of Plasmodium falciparum growth in culture by concanamycin A, a macrolide antibiotic inhibitor of vacuolar H(+)-ATPase derived from Streptomyces sp, was equivocal.


Assuntos
Amsacrina/análogos & derivados , Animais , Antimaláricos/farmacocinética , Antivirais/farmacocinética , Interações Medicamentosas , Quimioterapia Combinada , Hemina/farmacocinética , Humanos , Macrolídeos/farmacocinética , Plasmodium falciparum/efeitos dos fármacos
2.
Southeast Asian J Trop Med Public Health ; 2006 Jul; 37(4): 619-21
Artigo em Inglês | IMSEAR | ID: sea-33232

RESUMO

Concanamycin A, a macrolide antibiotic inhibitor of vacuolar H+-ATPase derived from Streptomyces sp, inhibited Plasmodium falciparum K1 growth in culture with an IC500 value of 0.2 nM. It exhibited an additive effect when tested together with the antimalarial pyronaridine.


Assuntos
Animais , Antimaláricos/toxicidade , Concentração Inibidora 50 , Macrolídeos/toxicidade , Naftiridinas/toxicidade , Plasmodium falciparum/efeitos dos fármacos
3.
Southeast Asian J Trop Med Public Health ; 2006 Jul; 37(4): 607-12
Artigo em Inglês | IMSEAR | ID: sea-31224

RESUMO

Sixteen antimalarial alkoxylated and hydroxylated chalcones were tested for their ability to inhibit recombinant plasmepsin II in vitro. The best inhibitory compounds had either a chloro or dimethylamino group at the 4-position of phenyl ring A in the chalcone template. Combination of the chalcones with chloroquine showed additivity or mild antagonism of Plasmodium falciparum K1 growth in culture.


Assuntos
Animais , Antimaláricos/farmacologia , Ácido Aspártico Endopeptidases/antagonistas & inibidores , Chalconas/química , Cloroquina/toxicidade , Concentração Inibidora 50 , Estrutura Molecular , Plasmodium falciparum/efeitos dos fármacos
4.
Artigo em Inglês | IMSEAR | ID: sea-37396

RESUMO

Curcumin is the main biologically active phytochemical compound in turmeric. It has been shown to have anticarcinogenic activity. The aims of the study were to identify the mechanism of apoptosis of HL-60 human promyelocytic leukemic cells induced by curcumin and to determine the effects of water-soluble antioxidants, ascorbic acid, Trolox (a water-soluble form of vitamin E), glutathione (GSH) and N-acetylcysteine (NAC) on this process. HL-60 cells were incubated with curcumin for 24 h and apoptotic cells were quantitated by flow cytometry following staining with annexin V-FITC and propidium iodide. Curcumin-treated HL-60 cells produced reactive oxygen species as detected by the dichlorofluorescein fluorescent assay. Apoptosis occurred via the mitochondria pathway as curcumin reduced mitochondrial membrane potential in a dose-dependent manner. In the presence of 10 microM curcumin, vitamin C (56 nM-5.6 microM) inhibited apoptosis of HL-60 cells; GSH at low concentration (1 microM) reduced apoptosis but had no effect at higher concentrations (10, 100 microM); and Trolox and NAC at 10 and 100 microM, respectively, enhanced apoptosis, but this effect was abolished at higher concentration (1 mM) of NAC. MAPKK/MEK inhibitor PD98059, enhanced curcumin-induced HL-60 apoptotic cell death.


Assuntos
Antineoplásicos/farmacologia , Antioxidantes/química , Apoptose/efeitos dos fármacos , Proteínas Quinases Dependentes de Cálcio-Calmodulina/antagonistas & inibidores , Curcumina/farmacologia , Relação Dose-Resposta a Droga , Flavonoides/farmacologia , Células HL-60 , Humanos , Potenciais da Membrana/efeitos dos fármacos , Mitocôndrias , Solubilidade
5.
Southeast Asian J Trop Med Public Health ; 2004 Dec; 35(4): 840-4
Artigo em Inglês | IMSEAR | ID: sea-36364

RESUMO

The appearance of drug resistant parasites and the absence of an effective vaccine have resulted in the need for new effective antimalarial drugs. Consequently, a convenient method for in vitro screening of large numbers of antimalarial drug candidates has become apparent. The CyQUANT cell proliferation assay is a highly sensitive fluorescence-based method for quantitation of cell number by measuring the strong fluorescence produced when green GR dye binds to nucleic acids. We have applied the CyQUANT assay method to evaluate the growth of Plasmodium falciparum D6 strain in culture. The GR-nucleic acid fluorescence linearly correlated with percent parasitemia at both 0.75 or 1 percent hematocrit with the same correlation coefficient of r2 = 0.99. The sensitivity of P. falciparum D6 strain to chloroquine and to 3,6-bis-omega-diethylaminoamyloxyxanthone, a novel antimalarial, determined by the CyQUANT assay were comparable to those obtained by the traditional [3H]-ethanolamine assay: IC50 value of chloroquine was 54 nM and 51 nM by the CyQUANT and [3H]-ethanolamine assay, respectively; IC50 value for 3,6-bis-omega-diethylaminoamyloxyxanthone was 254 nM and 223 nM by the CyQUANT and [3H]-ethanolamine assay, respectively. This procedure requires no radioisotope, uses simple equipment, and is an easy and convenient procedure, with no washing and harvesting steps. Moreover, all procedures can be set up continuously and thus, the CyQUANT assay is suitable in automatic high through-put drug screening of antimalarial drugs.


Assuntos
Animais , Antimaláricos/farmacologia , Células Cultivadas , Avaliação Pré-Clínica de Medicamentos/métodos , Humanos , Plasmodium falciparum/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA